NBAT1 and ovarian carcinoma: Additionally, for other systems, NBAT-1 can affect the prognosis of other cancers.—In epithelial ovarian cancer (EOC), Changsheng Yan verified that NBAT-1 acts as an anti-oncogene and can be potentially used in EOC therapy by targeting the ERK1/2 and AKT signalling pathways [31].